1. Home
  2. NWTG vs LYRA Comparison

NWTG vs LYRA Comparison

Compare NWTG & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc. Common Stock

NWTG

Newton Golf Company Inc. Common Stock

HOLD

Current Price

$1.85

Market Cap

7.1M

ML Signal

HOLD

Logo Lyra Therapeutics Inc.

LYRA

Lyra Therapeutics Inc.

N/A

Current Price

$4.28

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NWTG
LYRA
Founded
2018
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
7.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NWTG
LYRA
Price
$1.85
$4.28
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
173.3K
95.9K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,931,000.00
$600,000.00
Revenue This Year
$120.41
N/A
Revenue Next Year
$70.24
$93.90
P/E Ratio
N/A
N/A
Revenue Growth
178.24
N/A
52 Week Low
$0.82
$2.84
52 Week High
$49.80
$37.50

Technical Indicators

Market Signals
Indicator
NWTG
LYRA
Relative Strength Index (RSI) 67.16 51.94
Support Level $1.49 $3.47
Resistance Level $1.75 $4.16
Average True Range (ATR) 0.18 0.42
MACD 0.08 0.21
Stochastic Oscillator 91.02 95.25

Price Performance

Historical Comparison
NWTG
LYRA

About NWTG Newton Golf Company Inc. Common Stock

Newton Golf Co Inc is a technology-forward golf company dedicated to revolutionizing the sport with cutting-edge, high-performance products. The company's expanding portfolio includes golf shafts, putters, grips, and other golf-related accessories designed for golfers of all skill levels. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf, as well as through mass merchants and corporate customers in the Americas, Asia, and Europe.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: